It has also been reported that sorafenib‐resistant HCC cells have increased tumorigenic potential and show higher expression of stem‐related genes (NANOG, Oct4, CD133 and alpha fetoprotein) and lower levels of AMPK phosphorylation in vitro and in vivo.48 This evidence concerns the gene NANOG and hepatocellular carcinoma.